Kura Oncology Income Statement (2010-2026) | KURA

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)																14.11M	15.29M	20.75M	17.34M	18.27M
Gross Profit (Quarter)																14.11M				18.00M
Operating items
Research & Development (Quarter)	21.07M	22.37M	20.96M	20.91M	24.26M	24.97M	22.67M	25.19M	28.18M	29.33M	32.53M	36.27M	39.73M	41.70M	52.27M	55.97M				65.26M
Selling, General & Administrative (Quarter)	12.57M	11.31M	12.08M	11.87M	11.07M	11.62M	12.49M	11.37M	11.82M	13.14M	14.23M	18.18M	16.68M	18.18M	24.07M	22.84M				31.55M
Other Operating Expenses (Quarter)																				0.26M
Operating Expenses (Quarter)	33.65M	33.68M	33.04M	32.78M	35.33M	36.59M	35.16M	36.57M	40.00M	42.47M	46.76M	54.45M	56.40M	59.88M	76.34M	78.81M				97.08M
Operating Income (Quarter)																-64.70M				-78.81M
EBIT (Quarter)												-49.02M	-50.34M	-53.99M	155.09M	-64.70M	-41.05M	-73.62M	-80.58M	-78.81M
Non-operating items
Interest & Investment Income (Quarter)	0.29M	0.31M	0.29M	0.33M	0.56M	1.09M	2.27M	2.14M	0.67M	4.28M	7.64M	5.33M	0.35M	5.89M	-15.15M	7.88M				5.83M
Other Non Operating Income (Quarter)
Non Operating Income (Quarter)	-0.02M	0.31M	0.29M	0.33M	0.56M	1.09M	2.04M	2.50M	2.83M	3.87M	3.98M	4.93M	5.57M	5.48M	5.26M	7.50M				5.49M
Net income details
EBT (Quarter)												-49.52M	-50.84M	-54.40M	154.77M	-57.20M	-66.12M	-74.12M	-80.93M	-73.33M
Tax Provisions (Quarter)																0.23M			0.07M	0.01M
Profit After Tax (Quarter)	-33.97M	-33.37M	-34.34M	-32.45M	-34.77M	-35.50M	-25.49M	-34.07M	-37.17M	-36.91M	-42.79M	-49.52M	-50.84M	-52.83M	-19.22M	-57.22M	-66.12M	-74.12M	-81.15M	-74.74M
Income from Non-Controlling Interests (Quarter)													0.35M	1.58M		0.21M	-0.26M	0.21M		-1.40M
Income from Continuing Operations (Quarter)												-49.52M	-50.84M	-54.40M	154.77M	-57.43M	-66.12M	-74.12M	-81.00M	-73.33M
Consolidated Net Income (Quarter)												-49.52M	-50.84M	-54.40M	154.77M	-57.43M	-66.12M	-74.12M	-81.00M	-73.33M
Income towards Parent Company (Quarter)												-49.52M	-50.84M	-54.40M	154.77M	-57.43M	-66.12M	-74.12M	-81.00M	-73.33M
Net Income towards Common Stockholders (Quarter)												-49.52M	-50.84M	-54.40M	154.77M	-57.43M	-66.12M	-74.12M	-81.00M	-73.33M
Additional items
EPS (Basic) (Quarter)												-0.59	-0.59	-0.63	1.80	-0.66	-0.75	-0.85	-0.92	-0.83
EPS (Diluted) (Quarter)												-0.59	-0.59	-0.63	1.80	-0.66	-0.75	-0.85	-0.92	-0.83
Shares Outstanding (Quarter)	66.28M	66.35M	66.35M	66.61M	66.67M	66.89M	66.99M	68.40M	69.80M	77.24M	73.23M	83.91M	86.64M	86.95M	86.16M	87.42M	87.59M	87.64M	87.68M	88.61M
Shares Outstanding (Diluted) (Quarter)	66.28M	66.35M	66.35M	66.61M	66.67M	66.89M	66.99M	68.40M	69.80M	77.24M	73.23M	83.91M	86.64M	86.95M	86.16M	87.42M	87.59M	87.64M	87.68M	88.61M
EBITDA (Quarter)												-49.02M	-50.34M	-53.99M	155.09M	-64.70M	-41.05M	-73.62M	-80.58M	-78.81M
Interest Expenses (Quarter)	0.50M	1.86M	-1.09M	0.60M	0.60M	5.75M	0.60M	0.60M	0.60M	11.83M	-0.15M	0.50M	0.50M	0.41M	0.32M	0.40M	25.07M	0.50M	0.35M	7.90M
Tax Rate (Quarter)																-0.40			-0.09	-0.01

Research Tools

Developers

Kura Oncology Income Statement (2010-2026) | KURA

Research Tools

Developers

Kura Oncology Income Statement (2010-2026) | KURA

Create an account

Sign In

Reset Password